http://www.xconomy.com/boston/2009/03/11/biogen-idec-genentechs-rituxan-fails-in-pivotal-study-of-lupus-of-kidneys/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2009/03/11/biogen-idec-genentechs-rituxan-fails-in-pivotal-study-of-lupus-of-kidneys/comment-page-1/#comment-50535 Antibody Industry Week in Review | 3.16.09 — The Antibody Blog Mon, 16 Mar 2009 05:10:08 +0000 http://www.xconomy.com/?p=15777#comment-50535 [...] (rituximab; Biogen Idec / Genentech) failed a phase III trial in lupus [...] [...] (rituximab; Biogen Idec / Genentech) failed a phase III trial in lupus [...]

]]> http://www.xconomy.com/boston/2009/03/11/biogen-idec-genentechs-rituxan-fails-in-pivotal-study-of-lupus-of-kidneys/comment-page-1/#comment-49988 News, Money and Drugs - Wednesday, March 11, 2009 | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries Thu, 12 Mar 2009 00:53:22 +0000 http://www.xconomy.com/?p=15777#comment-49988 [...] -Another lupus drug goes belly up. This time, it’s Biogen and Genentech. [Xconomy] [...] [...] -Another lupus drug goes belly up. This time, it’s Biogen and Genentech. [Xconomy] [...]

]]>